Prostate cancer disparities between Black and White men remain one of oncology's most persistent and poorly explained gaps — and a new narrative review suggests that body fat, particularly the fat tissue immediately surrounding the prostate, may be a biologically active modifier of that gap, not merely a passive bystander. This reframes how researchers and clinicians should think about obesity and cancer risk in racially stratified populations.
The review, published in the European Journal of Cancer Prevention, synthesized evidence on visceral adiposity and periprostatic adipose tissue (PPAT) in relation to prostate cancer risk and aggressiveness across racial groups. A counterintuitive central finding emerges: Black men on average carry lower volumes of visceral and periprostatic fat compared to White men, yet these fat depots appear to exert disproportionately stronger biological effects in Black men. The authors hypothesize this may stem from differences in adipose tissue inflammatory signaling profiles or fat composition — mechanisms that remain incompletely characterized. A directed acyclic graph was developed to model hypothesized causal pathways. Notably, waist-hip ratio and PPAT were identified as potential amplifiers of aggressive prostate cancer features specifically in Black men, while appearing to have attenuated or inverse associations in non-Black men.
This finding challenges the assumption that adiposity functions uniformly across populations and raises the possibility that fat tissue quality, not just quantity, drives oncologic risk. From a broader research perspective, this review is consistent with emerging literature suggesting that adipose tissue is an endocrine and immune-active organ whose behavior is context-dependent. However, as a narrative review rather than a systematic meta-analysis, the evidence synthesis carries inherent selection bias risk. Most underlying studies are observational and face residual confounding from socioeconomic factors, dietary patterns, and healthcare access — all of which co-vary with both race and adiposity. This is an incremental but directionally important contribution: it provides a conceptual framework and signals that racially stratified adiposity phenotyping could eventually inform more targeted prostate cancer screening or intervention strategies.